+ 0.00
+ 0%
+ 0.00
+ 0%
+ 0.00
+ 0%
+ 0.00
+ 0%
+ 0.00
+ 0%

Medical Cannabis Innovator Grow Group Seeks Investors For Series C Fundraising Campaign

November 13, 2020 8:56 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Medical Cannabis Innovator Grow Group Seeks Investors For Series C Fundraising Campaign

Cannabis-focused biopharmaceutical company Grow Group PLC seeks to raise £6 million (US$7.9 million) in Series C funds.

The London-based company aims to use the capital to support further growth of its UK activities and speed-up its international expansion. Its goal is to become the biggest supplier of medical cannabis by patient numbers in the world by 2025.

Grow Group noted that UK taxpayers who decide to support its equity campaign can likely take advantage of Enterprise Investment Scheme tax benefits.

"We've been fortunate to enjoy fantastic support in the past from shareholders who genuinely believe that our laser focus on patient wellbeing will drive ethical commercial success," Grow CEO Ben Langley. "We look forward to welcoming new shareholders to the Grow family at this hugely exciting time for Grow, for the industry, and, most importantly, for patients globally."

Grow is seeking funds from "sophisticated and high net worth investors.”

Also, the recent FCA proclamation that UK licensed medical companies are able to list on a UK stock exchange offers “medium term exit potential.”

"The recent FCA guidance to allow UK licensed medical cannabis companies to list on UK exchanges has finally provided investors the necessary clarity to feel confident in backing this exciting and fast moving industry," Dean Gainsley, Non-Executive Director of Grow and cannabis industry advisor stated. "Coupled with the huge growth of the medical cannabis market around the world, this Series-C raise provides an exceptional window of opportunity to participate in the success of the UKs leading medical cannabis business.”

In addition, Grow Group noted that the European medical cannabis markets is projected to reach $3.3 billion, while the global medical cannabis should account for $14.4 billion by 2024.

Related Articles

Cannabis Stock Gainers And Losers From January 19, 2021

GAINERS: High Tide (OTCQB: HITIF) shares closed up 42.4% at $0.30 read more

Arkansas Medical Weed Sales Reach $175M In 2020, Projected To Double In 2021

Arkansas welcomed medical marijuana sales back in May 2019, only to see substantial market growth last year, with sales hitting the $175 million mark, reports Marijuana Business Daily. There was a record $1.22 million day, per Marijuana Business Factbook estimates. read more

Cannabis Movers & Shakers: Vireo Health, Flora, MJardin, Arcview, Viridian Capital Advisors

Here is a summary of the latest leadership changes within the cannabis industry. read more

Juva Life Obtains California Cultivation License For Stockton Facility

Life sciences company Juva Life Inc. (CSE: JUVA) (OTCQX: JUVAF) has obtained a state-approved cannabis cultivation license for its 30,000 square-foot facility in Stockton, California. read more